site banner

Eli Lilly releases data for a new weight-loss drug to tackle obesity : Shots - Health News : NPR

npr.org

This drug is a true gamechanger

In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.

this is comparable to bariatric surgery

11
Jump in the discussion.

No email address required.

That’s a pretty strong claim, do you have any evidence that ozempic or this drug doesn’t actually work?

What I mean is they won't eliminate overweight people, as the results aren't that good.

Moreover, it was natural for people not to become obese with very few exceptions. The drug is merely fixing the issues that we have created in recent years. It is not an improvement, merely preventing more harm that we are causing to ourselves.

That's the hope.